Rex John F's Form 4 filing
UnitedHealth Group IncUNH · filed Jul 29, 2022
- Accession no.
- 0001209191-22-043563
- Filed
- Jul 29, 2022
- Trade date
- Jul 29, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.14M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rex John FCIK 0001676672 | Officer (EVP Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock | MOption exerciseAcquired | +44,757 | $70.24 | +$3,143,731.68 | 179,673.26 | Direct | |
| Jul 29, 2022 | Common Stock | FTax withholdingDisposed | −24,982 | $539.37 | −$13,474,541.34 | 154,691.26 | Direct | |
| Jul 29, 2022 | Common Stock | SSaleDisposed | −13,183 | $541.53F1 | −$7,138,989.99 | 141,508.26 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock | MOption exerciseDisposed | −44,757 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades ranging from $538.945 to $543.72 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.